Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Study reveals how alcohol addiction and childhood stress rewire fear responses

NCT ID NCT02438969

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Sep 17, 2026 · Updated 3 times

Summary

This study looked at whether people with alcohol dependence or a history of early life stress have more trouble learning to feel calm after a scary event. Researchers used brain scans, mild electric shocks, and genetic tests to understand these differences. The goal was to learn more about how fear and anxiety work in these groups, not to test a new treatment.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

96 people

The number who actually took part.

Started

Aug 2015

Finished

Dec 2022

Lead sponsor

A government research agency

The lead sponsor is the US National Institutes of Health.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

AUD participants will be recruited from participants in the NIAAA screening platform protocols 14-AA-0181. Non-AUD participants will be recruited from participants in the NIAAA protocol 14-AA-0181. We will recruit all racial and ethnic groups in the greater Washington DC area

Ages

21 to 65 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

* INCLUSION AND EXCLUSION CRITERIA: Inclusion and exclusion criteria will be evaluated following screening conducted under the NIAAA screening protocols (98-AA-009 and/or 14-AA-0181). INCLUSION CRITERIA: INCLUSION CRITERIA FOR AUD GROUP: * Between 21 and 65 years of age * Ability to provide written informed consent as determined by successful completion of consent quiz prior to signing consent * Females: Negative urine pregnancy test, not currently breastfeeding, agree to abstain or use accepted form of contraception * Diagnosed with current alcohol dependence according to Diagnostic and Statistical Manual for Mental Disorders-Fourth Edition (DSM IV) * Alcohol consumption within the past month provided by self-report * Specify alcohol as their preferred drug in a clinical interview * 98-AA-0009 and/or 14-AA-0181 screening consents signed * Cleared venous access assessment * Additional inclusion criteria for non-treatment seeking AUD: Able and willing to abstain from consuming alcohol 1 day prior to each study visit INCLUSION CRITERIA FOR NON-AUD (HEALTHY VOLUNTEER) GROUP: * Between 21 and 65 years of age * Ability to provide written informed consent as determined by successful completion of consent quiz prior to signing consent * Females: Negative urine pregnancy test, not currently breastfeeding, agree to abstain or use accepted form of contraception * 98-AA-0009 and/or 14-AA-0181 screening consents signed * Cleared venous access assessment EXCLUSION CRITERIA: EXCLUSION CRITERIA FOR AUD GROUP: * Neurological symptoms of the wrist or arm, e.g., carpal tunnel syndrome, as determined by history and physical exam * Chronic use of psychotropic medications within four weeks of the study, with the exception of fluoxetine, for which the exclusionary time period is six weeks. Incidental use of psychotropic medications is allowed, but any use must be discontinued prior to the study for a time period exceeding 5 half-lives of the medication in question. * Presence of any current or past DSM IV diagnosis of bipolar disorder, or psychotic disorder (e.g, schizophrenia, schizoaffective disorder), or current substance dependence other than alcohol, nicotine, or caffeine. * Major medical problems (e.g., central nervous system (CNS), cardiovascular, respiratory, gastrointestinal (GI), hepatic, renal, endocrine, HIV, reproductive) that in the judgment of the PI, in consultation with relevant Clinical Center consult services, cannot be adequately managed at the Clinical Center. * Presence of ferromagnetic objects in the body, fear of enclosed spaces, or other standard contraindication to MRI, as determined by self-report * Left-handedness * Use of intrauterine device (IUD) * Excluded from the optional DEX-CRH test if: * Allergy to dexamethasone or CRH * Use of medications that can affect the results of the test, including certain antibiotics, anti-seizure drugs, corticosteroids, and hormonal contraception * Additional exclusionary criteria for non-treatment seeking AUD: * Presence of significant alcohol withdrawal symptoms, defined as a CIWA-Ar \> 8. * History of epilepsy or alcohol-related seizures. * Are currently seeking treatment for alcohol problems EXCLUSION CRITERIA FOR NON-AUD (HEALTHY VOLUNTEER) GROUP: * Neurological symptoms of the wrist or arm, e.g., carpal tunnel syndrome, as determined by history and physical exam. * Chronic use of psychotropic medications within four weeks of the study, with the exception of fluoxetine, for which the exclusionary time period is six weeks. Incidental use of psychotropic medications is allowed, but any use must be discontinued prior to the study for a time period exceeding 5 half-lives of the medication in question. * Presence of any current or past DSM IV diagnosis of bipolar disorder, or psychotic disorder (e.g, schizophrenia, schizoaffective disorder), or substance dependence other than nicotine, or caffeine. * Major medical problems (e.g., CNS, cardiovascular, respiratory, GI, hepatic, renal, endocrine, HIV, reproductive) that in the judgment of the PI, in consultation with relevant Clinical Center consult services, cannot be adequately managed at the Clinical Center * Presence of ferromagnetic objects in the body, fear of enclosed spaces, or other standard contraindication to MRI, as determined by self-report * Current or past DSM IV diagnosis of alcohol dependence or abuse * Currently seeking treatment for alcohol problems as assessed by self-report * Positive urine drug test at screening (for opiates, cannabinoids, amphetamines, cocaine, benzodiazepines) * Positive breathalyzer test at screening * Alcohol abstainer (never consumed alcohol in entire life) * Left-handedness * Use of intrauterine device (IUD)

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Alcohol dependence are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • National Institutes of Health Clinical Center

    Bethesda, Maryland, 20892, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.